| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2329543C Fumaric acid microtablets |
| 02/06/2007 | CA2286903C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
| 02/03/2007 | CA2555410A1 Compositions and methods for enhancing immunity by chemoattractant adjuvants |
| 02/01/2007 | WO2007013824A1 Biologically active extracts from stephania brachyandra |
| 02/01/2007 | WO2007013673A1 Fused heterocycles as lck inhibitors |
| 02/01/2007 | WO2007013613A1 Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material |
| 02/01/2007 | WO2007013609A1 Fucoidan-derived oligosaccharide |
| 02/01/2007 | WO2007013588A1 Strain of turkey tail mushroom, extract from the same, and use of the same |
| 02/01/2007 | WO2007013147A1 Angiogenesis inhibitor and vascular regressive agent |
| 02/01/2007 | WO2006133654B1 USE OF NF-κB INHIBITOR FOR TREATING SEVERAL DISEASES |
| 02/01/2007 | WO2006074919A3 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS |
| 02/01/2007 | WO2004084822A3 Methods for inducing immune tolerance |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027205 Diarylmethyl derivatives as potassium channel modulators |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
| 02/01/2007 | US20070027086 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as antiinflammatory and immunomodulatory agent; inhibit the production of nitric oxide (NO) |
| 02/01/2007 | US20070026389 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/01/2007 | US20070026057 In vivo targeting of dendritic cells |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025990 Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| 02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 02/01/2007 | US20070025961 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| 02/01/2007 | US20070025959 Adjuvant combination formulations |
| 02/01/2007 | DE202006017660U1 Body or beauty caring agent, useful as (non)-medical nourishment supplying agent, comprises colloidal noble metal such as gold with at least one vegetable ethereal oil and/or a bio-polymer |
| 02/01/2007 | CA2617219A1 Compositions comprising fucoidan or a fucoidan hydrolysate and an immuno-stimulating material |
| 02/01/2007 | CA2616395A1 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 02/01/2007 | CA2615615A1 Anti-cd26 antibodies and methods of use thereof |
| 01/31/2007 | EP1748075A1 Recombinant chemokine-antigen vaccine |
| 01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1747216A1 Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 01/31/2007 | EP1746990A1 Use of mast cells inhibitors for treating patients exposed to chemical or biological weapons |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | EP1034000B1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral hiv infection |
| 01/31/2007 | CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor |
| 01/31/2007 | CN1905890A Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 01/31/2007 | CN1904059A Production method of konjak mannose using cellulase |
| 01/31/2007 | CN1903306A Traditional Chinese medicine bag for regulating balance of yin and yang, and its prepn. method |
| 01/31/2007 | CN1903294A Traditional Chinese medicine having functional of supplementing qi, disintoxication, expelling knot and harmonizing stomach, its prepn. method |
| 01/31/2007 | CN1903242A Total saponin of American ginseng and injection liquid thereof |
| 01/31/2007 | CN1903212A Application of methyl astragalin for preparing medicines |
| 01/31/2007 | CN1903172A Poloxamer thymic peptide alpha 1 long-acting temp.-sensing gel |
| 01/31/2007 | CN1297653C Composition comprising a lactobacillus pentosus strain and uses thereof |
| 01/31/2007 | CN1297555C Antagonists of MCP-q function and method of use thereof |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297299C Application of cocoa extract in preparing medication of anti irritability and anti inflammation, foodstuff and cosmetic |
| 01/31/2007 | CN1297298C Antiradiation health tea for improving immunity |
| 01/31/2007 | CN1297285C Becterin of Serratia marcescens for curing |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169794 Oxidation of a chemical intermediate |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169775 Amino methyl imidazoles as C5a receptor modulators |
| 01/30/2007 | US7169762 Prepared by reacting a culture solution obtained by preliminarily culturing basidiomycetes with a reaction mixture obtained by reacting bran extracts with an enzyme; use as food, medicine and feedstuff utilizing the physiological activity of the substance; |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169391 Oil in water emulsions; induction immunology response; antigens |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169378 Delivery of opioids through an inhalation route |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2247328C Neuropeptides originating in scorpion |
| 01/25/2007 | WO2007011941A2 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011293A1 Novel piperidine derivatives |
| 01/25/2007 | WO2007011044A1 Pharmaceutical composition comprising disulfide-linked hla-g dimer and process for production of disulfide-linked hla-g dimer |
| 01/25/2007 | WO2007011018A1 Rapidly disintegratable oral tablet |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010964A1 Indole derivative having pgd2 receptor antagonist activity |
| 01/25/2007 | WO2007010515A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 01/25/2007 | WO2007010406A2 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007010084A2 Immunostimulatory oligo- and polysaccharides and uses thereof |
| 01/25/2007 | WO2007009959A1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders |
| 01/25/2007 | WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 01/25/2007 | WO2007009388A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof |
| 01/25/2007 | WO2006131013A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 01/25/2007 | WO2006117400A3 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006069805A3 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 01/25/2007 | WO2005123128A3 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/25/2007 | WO2004108065A3 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 01/25/2007 | US20070021596 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021462 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/25/2007 | US20070021461 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |